Oscotec Inc.

Translating science into medicine
Sign Up
PRESS
FLT3/AXL Inhibitor (A... 2020.06.22  
회사연혁

Oscotec Inc.


CEO

James Kim Ph.D., D.D.S

  • Ph.D. in Biochemistry from Seoul National Univ.
  • Dankook Univ. Prof.
  • Harvard Medical School, Post-Doc.
CEO

Taeyoung Yoon Ph.D.

  • Ph.D. in Organic Chemistry from Yale Univ.
  • California Inst. of Technology, Post-Doc
  • Novartis Pharma., Principal Scientist
  • Dong-A ST Inc., SVP, Head of Research Center
CTO

Jung-Ho Kim Ph.D.

  • Ph.D. in Organic Chemistry from Univ. of Illinois at Urbana-Champaign
  • Stanford Univ., Post-Doc
  • Hanwha Chemical, Principal Scientist
CFO

Scott Lee MBA

  • Director/Management
  • MBA in Business Administration from Dankook Univ.

Genosco Inc.


CEO

John Koh Ph.D.

  • Ph.D. in Bio-organic Chemistry California Institute of Technology
  • LG Life Science, R&D Head
CTO

Steve Kim Ph.D. D.D.S

  • Ph.D. in Pharmacology from Seoul National Univ.
  • Dankook Univ. Prof.
  • Harvard Medical School, Post-Doc.
CFO

Kevin Yang B, Sc

  • Director/Management
  • B. Sc in Communication from Seoul National Univ.
© k2s0o1d6e0s8i2g7n. ALL RIGHTS RESERVED.
Requesting to the server, please wait.